Medical research report on therapeutic gas supplies unveiled by EIGA

The European Industrial Gases Association (EIGA) has recently published a mini white paper titled 'Guaranteeing High Quality Medicinal Gases in Europe'. This comprehensive document addresses the importance of harmonised guidelines for the on-site production of medicinal gases in European healthcare systems.

The paper explains that without these guidelines, there are several risks for European healthcare systems. It discusses the on-site production of medicinal gases by dedicated devices at hospital premises and the risks associated with the lack of harmonised guidelines.

Gaseous substances for patient inhalation, such as oxygen and air, are usually supplied to healthcare facilities as licensed drugs in defined packages. However, on-site production of medicinal gases is also possible, and the white paper covers EIGA's view on this topic.

The white paper continues to discuss the importance of harmonised guidelines for the on-site production of medicinal gases in European healthcare systems. It is focused on ensuring high quality medicinal gases in Europe and involves collaboration with the European Directorate for the Quality of Medicines & HealthCare (EDQM) and national health authorities.

The document discusses the on-site preparation of medicinal gases in healthcare facilities from the perspective of the European Industrial Gases Association (EIGA). It addresses the risks associated with the lack of harmonised guidelines and the benefits of having such guidelines in place.

In conclusion, the EIGA mini white paper serves as a valuable resource for understanding the importance of harmonised guidelines for the on-site production of medicinal gases in European healthcare systems. It emphasises the need for collaboration and coordination among industry associations, regulatory bodies, and national health authorities to ensure the highest quality of medicinal gases for patient care.